KEGG   DRUG: Doxecitine and doxribtimine
Entry
D13205            Mixture   Drug                                   
Name
Doxecitine and doxribtimine;
Kygevvi (TN)
Product
Component
Doxecitine [DR:D12465], Doxribtimine [DR:D12466]
Remark
ATC code: A16AX29
Product: D13205<US>
Efficacy
Methabolic disease therapeutic agent
Comment
Treatment of thymidine kinase 2 deficiency (TK2d)
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
    A16AX Various alimentary tract and metabolism products
     A16AX29 Doxecitine and doxribtimine
      D13205  Doxecitine and doxribtimine <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D13205
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D13205
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D13205
Pharmacogenomic biomarkers [br08341.html]
 Germline mutations in genetic disorder treatments
  D13205
Other DBs
PubChem: 522705655
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system